S&P 500   4,275.54 (+0.19%)
DOW   33,739.84 (+0.22%)
QQQ   350.45 (+0.47%)
AAPL   177.72 (-0.06%)
MSFT   325.23 (+0.57%)
META   261.56 (-0.77%)
GOOGL   121.90 (-0.49%)
AMZN   124.08 (+2.35%)
TSLA   227.94 (+1.50%)
NVDA   381.38 (+1.77%)
NIO   7.64 (-1.55%)
BABA   86.36 (+1.27%)
AMD   120.16 (+1.98%)
T   15.92 (-1.12%)
F   13.54 (-0.37%)
MU   64.97 (-3.12%)
CGC   0.71 (-2.34%)
GE   105.78 (-0.28%)
DIS   91.58 (-1.02%)
AMC   4.55 (-3.81%)
PFE   38.91 (+0.05%)
PYPL   64.39 (+0.55%)
NFLX   403.29 (+0.88%)
S&P 500   4,275.54 (+0.19%)
DOW   33,739.84 (+0.22%)
QQQ   350.45 (+0.47%)
AAPL   177.72 (-0.06%)
MSFT   325.23 (+0.57%)
META   261.56 (-0.77%)
GOOGL   121.90 (-0.49%)
AMZN   124.08 (+2.35%)
TSLA   227.94 (+1.50%)
NVDA   381.38 (+1.77%)
NIO   7.64 (-1.55%)
BABA   86.36 (+1.27%)
AMD   120.16 (+1.98%)
T   15.92 (-1.12%)
F   13.54 (-0.37%)
MU   64.97 (-3.12%)
CGC   0.71 (-2.34%)
GE   105.78 (-0.28%)
DIS   91.58 (-1.02%)
AMC   4.55 (-3.81%)
PFE   38.91 (+0.05%)
PYPL   64.39 (+0.55%)
NFLX   403.29 (+0.88%)
S&P 500   4,275.54 (+0.19%)
DOW   33,739.84 (+0.22%)
QQQ   350.45 (+0.47%)
AAPL   177.72 (-0.06%)
MSFT   325.23 (+0.57%)
META   261.56 (-0.77%)
GOOGL   121.90 (-0.49%)
AMZN   124.08 (+2.35%)
TSLA   227.94 (+1.50%)
NVDA   381.38 (+1.77%)
NIO   7.64 (-1.55%)
BABA   86.36 (+1.27%)
AMD   120.16 (+1.98%)
T   15.92 (-1.12%)
F   13.54 (-0.37%)
MU   64.97 (-3.12%)
CGC   0.71 (-2.34%)
GE   105.78 (-0.28%)
DIS   91.58 (-1.02%)
AMC   4.55 (-3.81%)
PFE   38.91 (+0.05%)
PYPL   64.39 (+0.55%)
NFLX   403.29 (+0.88%)
S&P 500   4,275.54 (+0.19%)
DOW   33,739.84 (+0.22%)
QQQ   350.45 (+0.47%)
AAPL   177.72 (-0.06%)
MSFT   325.23 (+0.57%)
META   261.56 (-0.77%)
GOOGL   121.90 (-0.49%)
AMZN   124.08 (+2.35%)
TSLA   227.94 (+1.50%)
NVDA   381.38 (+1.77%)
NIO   7.64 (-1.55%)
BABA   86.36 (+1.27%)
AMD   120.16 (+1.98%)
T   15.92 (-1.12%)
F   13.54 (-0.37%)
MU   64.97 (-3.12%)
CGC   0.71 (-2.34%)
GE   105.78 (-0.28%)
DIS   91.58 (-1.02%)
AMC   4.55 (-3.81%)
PFE   38.91 (+0.05%)
PYPL   64.39 (+0.55%)
NFLX   403.29 (+0.88%)
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Forecast, Price & News

$0.35
+0.00 (+0.72%)
(As of 09:30 AM ET)
Compare
Today's Range
$0.35
$0.35
50-Day Range
$0.02
$0.37
52-Week Range
$0.01
$5.10
Volume
356 shs
Average Volume
201,050 shs
Market Capitalization
$1.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Calithera Biosciences MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
3,641.0% Upside
$13.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.11
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars


CALA stock logo

About Calithera Biosciences (NASDAQ:CALA) Stock

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CALA Stock News Headlines

CALA - Calithera Biosciences, Inc.
The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
Cala Mariolu
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Cala Llombards
Calithera Biosciences to Liquidate >CALA
See More Headlines

CALA Price History

CALA Company Calendar

Last Earnings
11/08/2021
Today
6/08/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CALA
Fax
N/A
Employees
8
Year Founded
2010

Price Target and Rating

Average Stock Price Forecast
$13.00
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+3,668.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-39,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.75 million
Book Value
($0.40) per share

Miscellaneous

Free Float
4,550,000
Market Cap
$1.68 million
Optionable
Optionable
Beta
0.60

Social Links


Key Executives

  • Dr. Susan M. Molineaux Ph.D. (Age 69)
    Founder, CEO, Pres & Director
    Comp: $625.81k
  • Ms. Stephanie Wong (Age 49)
    CFO & Sec.
    Comp: $752.42k
  • Dr. Christopher J. Molineaux Ph.D. (Age 70)
    Sr. VP of Devel.
  • Mr. Frank Parlati Ph.D. (Age 54)
    Sr. VP of Research
  • Dr. Susan B. Demo Ph.D.
    Sr. VP of R&D Operations
  • Dr. Allison Dillon Ph.D.
    Sr. VP of Commercial & Portfolio Strategy













CALA Stock - Frequently Asked Questions

Should I buy or sell Calithera Biosciences stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calithera Biosciences in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CALA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CALA, but not buy additional shares or sell existing shares.
View CALA analyst ratings
or view top-rated stocks.

What is Calithera Biosciences' stock price forecast for 2023?

3 analysts have issued 12 month target prices for Calithera Biosciences' shares. Their CALA share price forecasts range from $8.00 to $18.00. On average, they expect the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 3,668.1% from the stock's current price.
View analysts price targets for CALA
or view top-rated stocks among Wall Street analysts.

How have CALA shares performed in 2023?

Calithera Biosciences' stock was trading at $3.26 at the start of the year. Since then, CALA stock has decreased by 89.4% and is now trading at $0.3450.
View the best growth stocks for 2023 here
.

When is Calithera Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our CALA earnings forecast
.

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) issued its quarterly earnings results on Monday, November, 8th. The biotechnology company reported ($3.00) EPS for the quarter, beating the consensus estimate of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter. During the same period in the previous year, the company posted ($6.40) earnings per share.

When did Calithera Biosciences' stock split?

Shares of Calithera Biosciences reverse split on the morning of Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

What is Calithera Biosciences' stock symbol?

Calithera Biosciences trades on the NASDAQ under the ticker symbol "CALA."

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calithera Biosciences' stock price today?

One share of CALA stock can currently be purchased for approximately $0.35.

How much money does Calithera Biosciences make?

Calithera Biosciences (NASDAQ:CALA) has a market capitalization of $1.68 million and generates $9.75 million in revenue each year. The biotechnology company earns $-39,650,000.00 in net income (profit) each year or ($25.60) on an earnings per share basis.

How can I contact Calithera Biosciences?

Calithera Biosciences' mailing address is 343 OYSTER POINT BLVD. SUITE 200, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.calithera.com. The biotechnology company can be reached via phone at (650) 870-1000 or via email at ir@calithera.com.

This page (NASDAQ:CALA) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -